Cargando…
Increase Paclitaxel Sensitivity to Better Suppress Serous Epithelial Ovarian Cancer via Ablating Androgen Receptor/Aryl Hydrocarbon Receptor-ABCG2 Axis
Background: Epithelial ovarian cancer (EOC) is one of the most lethal gynecological malignancies and presents chemoresistance after chemotherapy treatment. Androgen receptor (AR) has been known to participate in proliferation. Yet the mechanisms of the resistance of this drug and its linkage to the...
Autores principales: | Chung, Wei-Min, Ho, Yen-Ping, Chang, Wei-Chun, Dai, Yuan-Chang, Chen, Lumin, Hung, Yao-Ching, Ma, Wen-Lung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521308/ https://www.ncbi.nlm.nih.gov/pubmed/30986993 http://dx.doi.org/10.3390/cancers11040463 |
Ejemplares similares
-
Short androgen receptor poly‐glutamine‐promoted endometrial cancer is associated with benzo[a]pyrene‐mediated aryl hydrocarbon receptor activation
por: Chen, Lumin, et al.
Publicado: (2017) -
The aryl hydrocarbon receptor and the gut–brain axis
por: Barroso, Andreia, et al.
Publicado: (2021) -
Simultaneous inhibition of aryl hydrocarbon receptor (AhR) and Src abolishes androgen receptor signaling
por: Ghotbaddini, Maryam, et al.
Publicado: (2017) -
Androgen/Androgen Receptor Signaling in Ovarian Cancer: Molecular Regulation and Therapeutic Potentials
por: Chung, Wei-Min, et al.
Publicado: (2021) -
Carbidopa suppresses prostate cancer via aryl hydrocarbon receptor-mediated ubiquitination and degradation of androgen receptor
por: Chen, Zhiwei, et al.
Publicado: (2020)